Business Description
HLS Therapeutics is a Canadian specialty pharmaceutical company focused on bringing treatments for mental health and heart disease to patients in Canada, the United States, and beyond. Its product lineup includes medicines for schizophrenia, high cardiovascular risk, and heart disease, along with supporting tools that make blood monitoring safer and easier for patients on certain medications. The company also offers laboratory tests that measure drug levels in the blood and holds a royalty interest in a treatment for a rare bleeding disorder. HLS Therapeutics operates out of Etobicoke, Canada, and sells primarily through wholesalers and healthcare institutions.
